-

Kit Check Launches New Virtual Medication Intelligence™ Center

Interactive website provides a look at Kit Check’s solutions in action in a virtual 3D hospital

WASHINGTON--(BUSINESS WIRE)--Kit Check, the market leader in software solutions for item-level visibility in the pharmaceutical space, today announced the launch of its interactive Medication Intelligence™ Center for customers to virtually engage with Kit Check solutions working in the hospital. Presented in an engaging, storytelling format that includes scenarios from key stakeholders, the website features information about Kit Check’s offerings, including its evidence-based purchasing tool Bluesight Insights™, its namesake automated medication inventory management system Kit Check, its drug diversion monitoring solution Bluesight® for Controlled substances, which utilizes advanced artificial intelligence and machine learning techniques to help hospitals identify risk, and more.

The cutting-edge website, experience.kitcheck.com, visualizes the main areas of a virtual hospital, including the pharmacy and operating rooms to give users the feeling of being physically present in the environment. Vignettes of pharmacists and nurses at work showcase how Kit Check’s solutions are used for a range of automation needs that prioritize simplicity, visibility, and predictability across the entire drug supply chain. Key highlights of the site include in-depth information on:

  • RFID capabilities: Kit Check’s namesake product provides continuous medication oversight throughout the medication’s entire chain of custody.
  • Bluesight Insights: Kit Check’s newest product aggregates pricing and product information about pharmaceuticals directly from wholesalers to offer users the best option available, saving hospitals 1% to 3% of their usual spend.
  • Bluesight for Controlled Substances: This comprehensive drug diversion prevention software offers complete coverage of the OR, nursing floors and the pharmacy – providing 100% audit of all hospital procedural areas.
  • DoseID: Kit Check is a proud member of DoseID, the first member driven industry consortium for the use of RFID technology in the healthcare space, and shares the mission of ensuring the quality, performance, and interoperability of RFID-tagged, serialized drugs as they move through the supply chain.
  • Mobile Pharmacy: This streamlined, newly re-designed pharmacy cart is an efficient solution for restocking procedural areas of the hospital and uses tablet technology to log inventory in real time.
  • Webinars: A virtual theater for Kit Check-hosted webinars and events where industry leaders can meet, learn and earn continuing education credit.

“We’ve created a state-of-the-art virtual environment so that members of the hospital pharmacy community can engage with all aspects of pharmacy operations to learn more about the importance of item-level visibility throughout their organizations,” said Kevin MacDonald, CEO and co-founder of Kit Check. “Clinicians can explore how Kit Check solutions provide their hospital Medication Intelligence and enable efficient medication inventory management, prevent diversion, optimize medication budgets, and provide the best possible patient safety.”

About Kit Check

Kit Check is the leading provider of automated medication tracking and diversion detection solutions for hospital pharmacies in the U.S., bringing visibility, simplicity, and predictability to the complex world of medication supply management. Our groundbreaking Medication Intelligence™ platforms provide item level visibility, workflow simplicity and actionable analytics, empowering stakeholders to deliver the right medicine to the right patient at the right time, every time. To date, our more than 500 U.S. and Canadian hospital partners have tracked more than 120 million medications using Kit Check’s RFID product. Bluesight® for Controlled Substances software is currently in use in more than 100 hospitals including full health system implementations, with more than 15 million cases tracked, and was ranked #1 in the Drug Diversion Monitoring category in the 2019 Best in KLAS report. More information about Kit Check and our software solutions can be found at kitcheck.com.

Contacts

Jill Gross
Matter Health for Kit Check
kitcheck@matternow.com
978-518-4528

Kit Check


Release Summary
Kit Check today announced the launch of its interactive Medication Intelligence™ Center.
Release Versions

Contacts

Jill Gross
Matter Health for Kit Check
kitcheck@matternow.com
978-518-4528

More News From Kit Check

New Report from BluesightⓇ Sheds Light on U.S. Consumer Trust in Healthcare and Pharmaceutical Management

ALEXANDRIA, Va.--(BUSINESS WIRE)--BluesightⓇ, The Medication Intelligence™ Company, today published the results of a recent survey measuring U.S. consumers’ trust in the U.S. healthcare system and pharmaceutical industry, which revealed that trust in both is below average. The study also explored how prior knowledge about drug diversion – among other factors – may impact patient perception and decisions about where to seek care. “Through our suite of software solutions, Bluesight aims to provid...

Medication Intelligence Leader Kit CheckⓇ Rebrands as BluesightⓇ

LAS VEGAS--(BUSINESS WIRE)--Kit Check today announced that it has rebranded as BluesightⓇ, The Medication Intelligence™ Company, to reflect its comprehensive suite of software solutions, maintaining its commitment to helping hospitals better serve their patients and pursuing a future where the medication supply chain is more efficient and connected. Founded in 2011, Bluesight provides unit-level visibility of pharmaceutical products from manufacturing plant to patient, addressing challenges suc...

Kit Check Partners with Genixus™ to Introduce RFID-Tagged Propofol as the First Product Within the KinetiX™ Line of Ready-to-Administer Syringes

ALEXANDRIA, Va.--(BUSINESS WIRE)--Kit Check, the leading automation vendor in Medication Intelligence™, today announced that its proprietary Radio Frequency Identification (RFID) technology will be incorporated in the new KinetiX™ Propofol syringes being developed by Genixus™, a pharmaceutical company and FDA-registered repackager and 503B outsourcing provider focused on transforming acute and critical care medicines. Propofol is one of the most commonly used products in hospitals and health sy...
Back to Newsroom